(S)-ALPHA-氨基-2'-氯-5-(膦酰甲基)-[1,1'-联苯]-3-丙酸单铵盐
中文名称 | (S)-ALPHA-氨基-2'-氯-5-(膦酰甲基)-[1,1'-联苯]-3-丙酸单铵盐 |
---|---|
中文同义词 | (S)-ALPHA-氨基-2'-氯-5-(膦酰甲基)-[1,1'-联苯]-3-丙酸单铵盐;化合物 T12872;化合物 SDZ 220-581 AMMONIUM SALT |
英文名称 | SDZ 220-581 (AMMoniuM salt) |
英文同义词 | SDZ 220-581 (AMMoniuM salt);(S)-alpha-Amino-2'-chloro-5-(phosphonomethyl)-[1,1'-biphenyl]-3-propanoic acid monoammonium salt;Ammonium (S)-2-amino-3-(2'-chloro-5-(phosphonomethyl)-[1,1'-biphenyl]-3-yl)propanoate;SDZ 220-581 ammonium;SDZ 220581 Ammonium salt,SDZ 220 581 Ammonium salt |
CAS号 | 179411-94-0 |
分子式 | C16H20ClN2O5P |
分子量 | 386.77 |
EINECS号 | |
相关类别 | |
Mol文件 | 179411-94-0.mol |
结构式 |
(S)-ALPHA-氨基-2'-氯-5-(膦酰甲基)-[1,1'-联苯]-3-丙酸单铵盐 性质
储存条件 | Store at -20°C |
---|---|
溶解度 | 溶于二甲基亚砜 |
形态 | 固体 |
颜色 | 米白色至浅黄色 |
SDZ 220-581 Ammonium salt 是一种口服生物利用度,有效的竞争性的 NMDA 受体拮抗剂,pKi 值为 7.7。
pKi: 7.7 ( NMDA receptor )
SDZ 220-581 (3.2-32 mg/kg; oral administration; for 24 hours; male OF-l mice) treatment dose-dependently protects mice against maximal electroshock seizures (MES). The time-course of protection by SDZ 220-581 is characterized by a rapid onset and long duration of action.
Animal Model: | Male OF-l mice (18-26 g) |
Dosage: | 3.2 mg/kg, 10 mg/kg, 32 mg/kg |
Administration: | Oral administration; for 24 hours |
Result: | Dose-dependently protected mice against maximal electroshock seizures (MES) upon oral administration. |
安全信息
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/08/19 | HY-13059A | SDZ 220-581 Ammonium salt | 5 mg | 550元 | |
2024/08/19 | HY-13059A | (S)-ALPHA-氨基-2'-氯-5-(膦酰甲基)-[1,1'-联苯]-3-丙酸单铵盐 SDZ 220-581 Ammonium salt | 179411-94-0 | 10mg | 1000元 |